Company intelligence / Profile preview

Mandra Capital

Hong Kong, China

Ownership: Private
Development stage: Other

Overview

Mandra Capital is a Hong Kong-based investment firm that focuses on long-term investments in the global healthcare, life sciences, and technology sectors. Founded by Song Yi, the firm acts as a strategic partner to its portfolio companies, providing capital and industry expertise to drive growth and innovation. Mandra Capital has a significant track record in the biotechnology space, having backed prominent companies such as Akeso and Legend Biotech. The firm typically engages in early-stage venture through to growth-stage private equity investments, leveraging its deep network to navigate complex global markets.

Industry: Investors

Beyond the preview

Go deeper on Mandra Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mandra Capital.

Explore the full profile